Investors

• Announcements
• 2012
• 08: BioPortos NGAL cutoff-patent – vurdering af afgørelse i indsigelsessag
• 07: BioPortos NGAL cutoff-patent - skriftlig afgørelse i indsigelsessag
• 06: Development of Annual General Meeting
• 05: Annual General Meeting
• 04: The NGAL test registered for diagnostic use in China
• 03: Annual report 2011
• 02: BioPorto’s NGAL cut-off patent rejected following a decision in the opposition case
• 01: Announcement from major shareholder
• 2011
• 2010
• 2009
• 2008
• 2007
• 2006
• 2005
• 2004
• Presentations
• Key Figures
• Financial Calendar 2012
• Analyst coverage
• Company Documents
• News mail
• Contact investor relations